• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

藏身于众目睽睽之下:基于表位的亚单位疟疾疫苗策略。

Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine.

机构信息

Institute for Glycomics, Griffith University, Gold Coast, Australia.

University of Alberta, Edmonton, Canada.

出版信息

Trends Parasitol. 2023 Nov;39(11):929-935. doi: 10.1016/j.pt.2023.08.006. Epub 2023 Sep 6.

DOI:10.1016/j.pt.2023.08.006
PMID:37684152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10592166/
Abstract

Recent data suggest that approaches to developing a subunit blood-stage malaria vaccine may be misdirected. While antigenic polymorphism is recognized as a challenge, efforts to counter this have primarily involved enhancing the quantity and quality of antibody with potent adjuvants, identifying conserved target proteins, or combining multiple antigens to broaden the immune response. However, paradoxically, evidence has emerged that narrowing, rather than broadening, the immune response may be required to obtain an immune response protective against multiple Plasmodium strains. Non-immunodominant, conserved epitopes are crucial. The evidence comes from studying the immune response to red cell surface-expressed antigens but should also be applicable to merozoite surface antigens. Strategies to define the targets of these highly focused immune responses are provided.

摘要

最近的数据表明,开发亚单位血阶段疟疾疫苗的方法可能是错误的。虽然抗原多态性被认为是一个挑战,但为了应对这一挑战,人们主要致力于通过使用有效的佐剂来提高抗体的数量和质量,鉴定保守的靶蛋白,或结合多种抗原来扩大免疫反应。然而,矛盾的是,有证据表明,为了获得针对多种疟原虫株的免疫反应,缩小而不是扩大免疫反应可能是必要的。非免疫显性、保守表位至关重要。这一证据来自于对红细胞表面表达抗原的免疫反应的研究,但也应该适用于裂殖子表面抗原。提供了用于定义这些高度集中的免疫反应的目标的策略。

相似文献

1
Hiding in plain sight: an epitope-based strategy for a subunit malaria vaccine.藏身于众目睽睽之下:基于表位的亚单位疟疾疫苗策略。
Trends Parasitol. 2023 Nov;39(11):929-935. doi: 10.1016/j.pt.2023.08.006. Epub 2023 Sep 6.
2
Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains.人体接种多态性疟疾疫苗候选物诱导产生针对保守表位的抗体,促进针对多种寄生虫株的功能性抗体。
J Infect Dis. 2018 Jun 5;218(1):35-43. doi: 10.1093/infdis/jiy170.
3
Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.双等位基因血期疟疾病毒载体疫苗免疫后对免疫干扰、拮抗和转移的评估及对照性疟疾感染。
J Immunol. 2013 Feb 1;190(3):1135-47. doi: 10.4049/jimmunol.1201455. Epub 2013 Jan 4.
4
Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues.所有疟原虫免疫表位数据的荟萃分析:疟疾免疫生物学及疫苗相关问题的概述与应用
Parasite Immunol. 2009 Feb;31(2):78-97. doi: 10.1111/j.1365-3024.2008.01077.x.
5
Prediction of merozoite surface protein 1 and apical membrane antigen 1 vaccine efficacies against Plasmodium chabaudi malaria based on prechallenge antibody responses.基于攻击前抗体反应预测裂殖子表面蛋白1和顶膜抗原1疫苗对查巴迪疟原虫疟疾的疗效
Clin Vaccine Immunol. 2009 Mar;16(3):293-302. doi: 10.1128/CVI.00230-08. Epub 2008 Dec 30.
6
Identification and characterization of protective CD8 T-epitopes in a malaria vaccine candidate SLTRiP.鉴定和分析疟疾候选疫苗 SLTRiP 中的保护性 CD8 T-表位。
Immun Inflamm Dis. 2020 Mar;8(1):50-61. doi: 10.1002/iid3.283. Epub 2020 Jan 22.
7
Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'.遗传多样性与疟疾疫苗的设计、测试及效力:预防和克服“抗疫苗疟疾”
Parasite Immunol. 2009 Sep;31(9):560-73. doi: 10.1111/j.1365-3024.2009.01138.x.
8
Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.一种嵌合恶性疟原虫裂殖子表面蛋白疫苗在夜猴中的免疫原性。
Malar J. 2016 Mar 15;15:159. doi: 10.1186/s12936-016-1226-5.
9
Our impasse in developing a malaria vaccine.我们在开发疟疾疫苗方面陷入了僵局。
Cell Mol Life Sci. 2011 Apr;68(7):1105-13. doi: 10.1007/s00018-011-0634-5. Epub 2011 Feb 15.
10
Pre-erythrocytic malaria vaccines: identifying the targets.红细胞前期疟疾疫苗:确定目标。
Expert Rev Vaccines. 2012 Oct;11(10):1261-80. doi: 10.1586/erv.12.92.

引用本文的文献

1
Designing a multi-epitope vaccine against the midgut-specific fibrinogen-related protein 1(FREP1) of Anopheles stephensi to enhance protection against the malaria parasite: a step beyond traditional vaccine development approaches.设计一种针对斯氏按蚊中肠特异性纤维蛋白原相关蛋白1(FREP1)的多表位疫苗,以增强对疟原虫的保护:超越传统疫苗开发方法的一步。
Biotechnol Lett. 2025 Sep 3;47(5):93. doi: 10.1007/s10529-025-03632-1.
2
Recent perspectives in clinical development of malaria vaccines.疟疾疫苗临床开发的最新观点。
Nat Commun. 2025 Apr 15;16(1):3565. doi: 10.1038/s41467-025-58963-4.
3
Protection acquired upon intraperitoneal group a immunization is independent of concurrent adaptive immune responses but relies on macrophages and IFN-γ.

本文引用的文献

1
A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?胎盘疟疾疫苗抗原 VAR2CSA 的构象表位:它能给我们什么启示?
PLoS Pathog. 2023 May 25;19(5):e1011370. doi: 10.1371/journal.ppat.1011370. eCollection 2023 May.
2
Anopheles stephensi in Africa: vector control opportunities for cobreeding An. stephensi and Aedes arbovirus vectors.非洲的斯氏按蚊:共栖斯氏按蚊与伊蚊虫媒病毒媒介的病媒控制机遇
Trends Parasitol. 2023 Feb;39(2):86-90. doi: 10.1016/j.pt.2022.11.011. Epub 2022 Dec 13.
3
The RTS,S malaria vaccine: Current impact and foundation for the future.
经腹腔注射A组免疫后获得的保护作用独立于同时发生的适应性免疫反应,但依赖于巨噬细胞和干扰素-γ。
Virulence. 2025 Dec;16(1):2457957. doi: 10.1080/21505594.2025.2457957. Epub 2025 Feb 8.
4
Detection of naturally acquired, strain-transcending antibodies against rosetting strains in humans.检测人类对成帽株的天然获得性、株系跨越抗体。
Infect Immun. 2024 Jul 11;92(7):e0001524. doi: 10.1128/iai.00015-24. Epub 2024 Jun 6.
RTS,S 疟疾疫苗:当前影响和未来基础。
Sci Transl Med. 2022 Nov 16;14(671):eabo6646. doi: 10.1126/scitranslmed.abo6646.
4
A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection.一种PfSPZ疫苗免疫方案对同源和异源受控人类疟疾感染具有同等的保护作用。
NPJ Vaccines. 2022 Aug 23;7(1):100. doi: 10.1038/s41541-022-00510-z.
5
Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.疟原虫环状体阶段的吞噬作用可预测疟疾的保护作用。
Nat Commun. 2022 Jul 14;13(1):4098. doi: 10.1038/s41467-022-31640-6.
6
Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean Adults.PfSPZ疫苗多剂量启动方案:在赤道几内亚成年人中对受控人类疟疾感染的安全性和有效性。
Am J Trop Med Hyg. 2022 Feb 7;106(4):1215-1226. doi: 10.4269/ajtmh.21-0942. Print 2022 Apr 6.
7
A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.单一全长 VAR2CSA 外显区变体可纯化针对胎盘疟疾分离株的广谱中和抗体。
Elife. 2022 Feb 1;11:e76264. doi: 10.7554/eLife.76264.
8
Repeated infection in humans drives the clonal expansion of an adaptive γδ T cell repertoire.人类的反复感染驱动适应性 γδ T 细胞库的克隆扩增。
Sci Transl Med. 2021 Dec;13(622):eabe7430. doi: 10.1126/scitranslmed.abe7430. Epub 2021 Dec 1.
9
Malaria Vaccines and Vaccine Adjuvants.疟疾疫苗与疫苗佐剂
Vaccines (Basel). 2021 Sep 24;9(10):1072. doi: 10.3390/vaccines9101072.
10
Evidence of Artemisinin-Resistant Malaria in Africa.非洲出现青蒿素抗药性疟疾。
N Engl J Med. 2021 Sep 23;385(13):1163-1171. doi: 10.1056/NEJMoa2101746.